Investing Profile

Florian Müllershausen

InvestorVC

Managing Director at Novartis Venture Fund

nvfund.comBasel, Switzerland

Your Intro Paths to Florian Müllershausen

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Florian Müllershausen on

Current Investing Position

Investment Range

$5.0M - $10.0M

Sweet Spot

$7.5M

Investments On Record

Current Fund Size

$750M

Florian Müllershausen is on these Sector & Stage Rankings

Florian Müllershausen's Investments On Record (8)

Company	StageDateRound Size	Total Raised
Artios Pharma	Series DNov 2025$120M Series CJul 2021$150M Series BAug 2018$83M	$380M
Co-investors: Barbara Dalton (Pfizer Venture Investments), Jake Simson (RA Capital), René Kuijten (EQT Life Sciences), Hakan Goker (M Ventures (Merck)), Raphael Wisniewski (Andera Partners), Nikola Trbovic (Pfizer Venture Investments)
NRG Therapeutics	Series BSep 2025$68M	$86M
Co-investors: Jonathan Tobin (Brandon Capital Partners), Laurence Barker (SV Health Investors)
FoRx Therapeutics	Series AJun 2025$49M SeedApr 2020$11M	$110M
Co-investors: Therese Liechtenstein (M Ventures (Merck)), Denis Patrick (Pfizer Venture Investments), Vincent Ossipow (Omega Funds), Vincent Brichard
Rhygaze	Series AJan 2025$86M SeedJul 2024$11M	$97M
Co-investors: Daniela Couto (BGV (BioGeneration Ventures))
Citryll	Series BDec 2024$90M	$110M
Co-investors: Edward Van Wezel (BGV (BioGeneration Ventures)), Geert-Jan Mulder (Forbion), Isabelle de Cremoux (Seventure Partners)
LOQUS23 THERAPEUTICS	Series AOct 2024$46M SeedNov 2021$9M	$55M
Co-investors: Rogier Rooswinkel (Forbion)
Amphista Therapeutics	Series BMar 2021$53M	$61M
Co-investors: Satish Jindal (Advent Life Sciences), Raj Parekh (Advent Life Sciences), Rogier Rooswinkel (Forbion)
Anaveon	Series AFeb 2019$35M	$160M
Co-investors: Ohad Hammer (Pontifax Venture Capital), Jasper Bos (Forbion), Denis Patrick (Pfizer Venture Investments)